RNA markers for antidepressant response in depression
Treatments studied
Part of Mental health clinical trials.
This study looks at how RNA might help predict which antidepressant works best for you. It tests two medications: vortioxetine and cariprazine, in people with major depressive disorder or bipolar depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are currently experiencing a major depressive episode as part of major depressive disorder, bipolar I disorder, or bipolar II disorder.
- Your depression symptoms are at least moderate (score over 10 on a standard questionnaire).
- You can travel to the clinic for study visits.
- If you are a woman who could become pregnant, you must have a negative pregnancy test and use an effective birth control method.
- For bipolar I disorder, you must be on a stable dose of a mood stabilizer for at least one month before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.
This study uses a blood test (biomarker) to help pick the antidepressant that might work best for you. It compares two treatments—standard antidepressants and ketamine—in people with major depression who haven't gotten enough relief from one prior treatment.
This study looks at how certain molecules (called non-coding RNAs) relate to mental health conditions like bipolar disorder, depression, anxiety, OCD, or schizophrenia. By comparing patients who haven't been on psychiatric medication for at least 6 months with healthy volunteers, researchers hope to find better ways to diagnose and understand these conditions.
This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.
This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.
This trial tests whether using a website plus your genetic information helps doctors pick a better antidepressant for you. It aims to improve treatment for people with depression.
Hear when a new Bipolar Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.